Riociguat for pulmonary arterial hypertension (PAH)...

BMC Pharmacology and Toxicology 2015 / 12 Vol. 16; Iss. S1

Riociguat for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): A subgroup analysis from the PATENT studies

Stephan, Rosenkranz, Ghofrani, Hossein-Ardeschir, Beghetti, Maurice, Ivy, Dunbar, Fritsch, Arno, Weimann, Gerrit, Saleh, Soundos, Apitz, Christian, Frey, Reiner
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
BMC Pharmacology and Toxicology
DOI:
10.1186/2050-6511-16-S1-A79
Date:
December, 2015
File:
PDF, 374 KB
english, 2015
Conversion to is in progress
Conversion to is failed